Health ❯ Healthcare ❯ Clinical Research

Drug Trials

Efficacy Studies Personalized Treatments Eli Lilly Apitegromab Semaglutide for Smoking Cessation Real-World Studies Weight Management Studies GLP-1RA Studies Novo Nordisk Study FIND-CKD Study Comparative Effectiveness Research BCL2 Inhibitors Semaglutid Meta-Analysis Liraglutide and Semaglutide Rapamycin Effects Randomized Controlled Trials Peptide Efficacy Late-Stage Studies Statin Studies Combination Therapy Autoimmune Disorders Regulatory Approvals Semaglutide and Cardiovascular Outcomes Lecanemab Eli Lilly's Kisunla Wegovy Study Safety Monitoring Observational Studies Gepotidacin Study Side Effects Side Effects Monitoring Pancreatitis Cases Niraparib Study Weight Loss Studies

Finerenone Slows Kidney Decline in Non‑Diabetic CKD, Trial Shows

Presented June 5, 2026, FIND‑CKD suggests finerenone could broaden treatment options for people with chronic kidney disease without diabetes.

New Trials Show Daily Pills Can Help Maintain Weight Loss After GLP-1 Injections

FDA Clears Enhertu-Perjeta Combo for First-Line HER2-Positive Metastatic Breast Cancer

Sanofi, Dren Bio Set Autoimmune Collaboration Worth Up to $1.7 Billion With $100 Million Upfront

AbbVie Extends Rinvoq U.S. Exclusivity to 2037 as AI Biotechs Move From Models to Medicines